scholarly article | Q13442814 |
P2093 | author name string | Ahmed Mahmoud Abdelhaleem Ali | |
Ahmed Abdelbary Abdelrahman | |||
Eman Magdy Maher | |||
Heba Farouk Salem | |||
P2860 | cites work | Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers | Q28216525 |
Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. | Q33249551 | ||
Fast dissolving strips: A novel approach for the delivery of verapamil | Q34373809 | ||
Oral strip technology: overview and future potential | Q34989363 | ||
Characterization and optimization of orodispersible mosapride film formulations. | Q35577232 | ||
Characterization of oral disintegrating film containing donepezil for Alzheimer disease | Q35821872 | ||
Development and Characterization of a Vaginal Film Containing Dapivirine, a Non- nucleoside Reverse Transcriptase Inhibitor (NNRTI), for prevention of HIV-1 sexual transmission | Q36033871 | ||
A review on mouth dissolving films | Q37596472 | ||
Advances in orodispersible films for drug delivery | Q37834030 | ||
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle | Q37914880 | ||
Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. | Q37977737 | ||
Water soluble polymer films for intravascular drug delivery of antithrombotic biomolecules | Q39659901 | ||
Formation Mechanism of Coamorphous Drug-Amino Acid Mixtures. | Q40854029 | ||
Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model. | Q41032711 | ||
Formulation of a novel tianeptine sodium orodispersible film | Q41867207 | ||
Design of olanzapine/lutrol solid dispersions of improved stability and performances | Q41998882 | ||
Plasticizer effects on physical-mechanical properties of solvent cast Soluplus® films | Q42574249 | ||
Development of a taste-masked orodispersible film containing dimenhydrinate. | Q42876082 | ||
Optimization of propranolol HCl release kinetics from press coated sustained release tablets | Q44189428 | ||
Buccal films of prednisolone with enhanced bioavailability | Q45209173 | ||
Development of a buccal mucoadhesive film for fast dissolution: mathematical rationale, production and physicochemical characterization | Q45375065 | ||
Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement | Q45811011 | ||
Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. | Q46183523 | ||
Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use. | Q46513438 | ||
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies | Q48950555 | ||
Clozapine-carboxylic acid plasticized co-amorphous dispersions: Preparation, characterization and solution stability evaluation | Q50444533 | ||
Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. | Q51082669 | ||
Particle engineering/different film approaches for earlier absorption of meloxicam. | Q51137697 | ||
Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. | Q51542358 | ||
The effect of experimental design on the modeling of a tablet coating formulation using artificial neural networks. | Q52942583 | ||
Role of the Strength of Drug–Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions | Q57374585 | ||
Solid state characterization of olanzapine polymorphs using vibrational spectroscopy | Q58861836 | ||
Preparation and characterization of spray-dried co-amorphous drug-amino acid salts | Q59234161 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3088-3100 | |
P577 | publication date | 2016-03-10 | |
P1433 | published in | Drug Delivery | Q5308838 |
P1476 | title | In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids | |
P478 | volume | 23 |
Q91603846 | Advances in coamorphous drug delivery systems |
Q47267991 | Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide. |
Q64902990 | Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery. |
Q49496136 | Coamorphous Active Pharmaceutical Ingredient-Small Molecule Mixtures: Considerations in the Choice of Coformers for Enhancing Dissolution and Oral Bioavailability |
Q39410919 | Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles |
Q90477980 | In vitro and in vivo characterization of domperidone-loaded fast dissolving buccal films |
Search more.